#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5129610	B	Inhibition of NFATC activity in HEK293T cells at 5 to 50 uM preincubated for 2 hrs followed by ionomycin/phorbol 12-myristate 13-acetate stimulation and measured after 4 hrs by luciferase reporter assay	Homo sapiens	11		cell-based format	Scientific Literature
2.	ALA5129612	B	Inhibition of NFATC activity in HEK293T cells preincubated for 2 hrs followed by ionomycin/phorbol 12-myristate 13-acetate stimulation and measured after 4 hrs by luciferase reporter assay	Homo sapiens	7		cell-based format	Scientific Literature
3.	ALA5129613	B	Displacement of carboxyfluorescein labelled NFATc2 derived PRIEIT peptide from human CNAalpha (2 to 347 residues) at 10 to 100 uM preincubated for 15 mins followed by CF-PRIEIT addition and measured after 15 mins by fluorescence polarization assay	Homo sapiens	9		single protein format	Scientific Literature
4.	ALA5129614	B	Inhibition of NFATC activity in human PBMC cells assessed as reduction of IL2 gene expression preincubated for 2 hrs followed by ionomycin/phorbol 12-myristate 13-acetate stimulation and measured after 4 hrs by RT-PCR analysis	Homo sapiens	3		cell-based format	Scientific Literature
5.	ALA5129615	B	Inhibition of NFATC activity in human PBMC cells assessed as reduction of IFN gamma gene expression preincubated for 2 hrs followed by ionomycin/phorbol 12-myristate 13-acetate stimulation and measured after 4 hrs byRT-PCR analysis	Homo sapiens	3		cell-based format	Scientific Literature
6.	ALA5129616	B	Inhibition of NFATC activity in human CD4+ T cells assessed as reduction of IFN gamma secretion preincubated for 2 hrs followed by anti-CD3/CD28 stimulation and measured after 48 hrs by ELISA	Homo sapiens	3		cell-based format	Scientific Literature
7.	ALA5129617	B	Inhibition of NFATC activity in human CD4+ T cells assessed as reduction of IL-2 secretion preincubated for 2 hrs followed by anti-CD3/CD28 stimulation and measured after 48 hrs by ELISA	Homo sapiens	3		cell-based format	Scientific Literature
8.	ALA5129618	F	Immunosuppressive activity in human CD4+ve Th cells assessed as inhibition of T cell proliferation measured after 72 hrs by [3H]-thymidine incorporation based scintillation counter method	Homo sapiens	3		cell-based format	Scientific Literature
9.	ALA5129619	T	Toxicity in BALB/c mouse assessed as clinical signs of abnormal constitution at 50 mg/kg, ip administered for 5 days and measured on day 7	Mus musculus	2		organism-based format	Scientific Literature
10.	ALA5129620	T	Toxicity in BALB/c mouse assessed as aberrant behavior at 50 mg/kg, ip administered for 5 days and measured on day 7	Mus musculus	2		organism-based format	Scientific Literature
11.	ALA5129621	T	Toxicity in BALB/c mouse assessed as loss of body weight at 50 mg/kg, ip administered for 5 days and measured on day 7	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA5129622	T	Toxicity in BALB/c mouse xenografted with mouse 4T1 cells assessed as effect on body weight at 50 mg/kg, ip administered daily for 5 days	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA5129624	T	Toxicity in BALB/c mouse xenografted with mouse 4T1 cells assessed as effect on health conditions at 50 mg/kg, ip administered daily for 5 days	Mus musculus	2		organism-based format	Scientific Literature
14.	ALA5129627	F	Antitumor activity against mouse 4T1 cells xenografted in BALB/c mouse assessed as decrease in tumor weight at 5 mg/kg, ip measured after 15 days	Mus musculus	2		organism-based format	Scientific Literature
15.	ALA5129629	F	Anti-angiogenesis activity against mouse 4T1 cells xenografted in BALB/c mouse at 50 mg/kg, ip measured after 15 days by anti-CD31 staining based immunohistochemistry analysis	Mus musculus	2		organism-based format	Scientific Literature